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ABSTRACT 
BACKGROUND: Tumor Necrosis Factor-alpha (TNF-α) is one of the pro-
inflammatory cytokines that has been considered to be involved in the pathogenesis of 
periodontal disease as mediators of tissue destruction and serves as a biomarker for 
disease progression. Increased level of TNF-α has been identified in oral fluids of 
smokers. Recent advances have enabled the use of saliva as diagnostic fluid to detect 
the levels of these biomarkers. 
AIM: The aim of the present study is to compare the level of TNF-α in saliva of non-
smokers and smokers with chronic periodontitis before and after phase-I therapy. 
MATERIALS AND METHOD: Level of salivary TNF-α was determined in non-
smokers with chronic periodontitis (control group, n=15) and smokers with chronic 
periodontitis (study group, n=15) and compared with clinical parameters like gingival 
bleeding index, plaque index, probing pocket depth and clinical attachment level before 
and after phase-I therapy. 
RESULTS: Smokers had increased level of Salivary TNF-α compared to non-smokers 
at baseline. Statistically significant (p=0.00) reduction in clinical parameters and 
Salivary TNF-α level were seen among both non-smokers and smokers 3 months after 
Phase-I therapy. However, non-smokers showed significantly greater reduction in 
clinical parameters and Salivary TNF-α level compared to smokers.  
CONCLUSION: The present observations suggest that smoking is associated with 
elevated level of salivary TNF-α level and non-smokers exhibit better response to 
Phase-I therapy which is evident through significant decrease in level of salivary TNF-
α after phase-I therapy compared to smokers. 
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